印尼紧急批准了科兴的疫苗，有效率为65.3%。巴西有效率更新为50.4%

[eetimes]

印尼批准了科兴的疫苗，印尼本地做的临床实验中有效率为65.3%

Indonesia says China’s Sinovac vaccine 65.3 per cent effective

Indonesia also became the first country outside China to give the regulatory green light to the Sinovac Biotech vaccine.

www.scmp.com

 

[eetimes]

科兴疫苗的有效率现在有四种不同的说法：
土耳其 91%，印尼65%，巴西78%，以及巴西内部未经证实的50-60%之间

Sinovac's vaccine efficacy less than 60pct in Brazil trial -report

The coronavirus vaccine developed by China's Sinovac Biotech showed a general efficacy of less than 60% in its late-stage trial in Brazil, a news website reported on Monday, citing two people who seen the results.

news.abs-cbn.com

 

[eetimes]

科兴疫苗的有效率现在有四种不同的说法：
土耳其 91%，印尼65%，巴西78%，以及巴西内部未经证实的50-60%之间

Sinovac's vaccine efficacy less than 60pct in Brazil trial -report

The coronavirus vaccine developed by China's Sinovac Biotech showed a general efficacy of less than 60% in its late-stage trial in Brazil, a news website reported on Monday, citing two people who seen the results.

news.abs-cbn.com

Brazilian news website UOL reported that the efficacy rate that Butantan was set to announce on Tuesday was between 50% and 60% — above the threshold set by health regulators, but well below the numbers celebrated last week.

 

[eetimes]

RIO DE JANEIRO, Jan 12 (Reuters) - A coronavirus vaccine developed by China's Sinovac showed "general efficacy" of 50.38% in a late-stage trial in Brazil, the company's local partners said on Tuesday, revealing a more modest figure after pressure for more transparency.

On Thursday, Butantan officials had celebrated results showing 78% efficacy against mild COVID-19 cases, a rate they have since described as "clinical efficacy."

Ricardo Palacios, medical director for clinical research at the Butantan biomedical center in Sao Paulo, said the new figure included infections that were so mild or asymptomatic that they did not need clinical care. (Reporting by Gabriel Stargardter and Pedro Fonseca Editing by Brad Haynes)

China's Sinovac vaccine has "general efficacy" of 50.4% in Brazil trials, says Butantan

HEALTH–CORONAVIRUS/BRAZIL-CORONAVIRUS (URGENT):China's Sinovac vaccine has "general efficacy" of 50.4% in Brazil trials, says Butantan

news.trust.org

 

[eetimes]

不知道巴西mild or asymptomatic和送医的标准是什么？

 

[向问天]

the new figure included infections that were so mild or asymptomatic that they did not need clinical care

难怪

 

[eetimes]

辉瑞:
Confirmed Covid-19 was defined according to the Food and Drug Administration (FDA) criteria as the presence of at least one of the following symptoms: fever, new or increased cough, new or increased shortness of breath, chills, new or increased muscle pain, new loss of taste or smell, sore throat, diarrhea, or vomiting, combined with a respiratory specimen obtained during the symptomatic period or within 4 days before or after it that was positive for SARS-CoV-2 by nucleic acid amplification–based testing, either at the central laboratory or at a local testing facility (using a protocol-defined acceptable test).


科兴：
The definition of case caused by the 2019 SARS-CoV-2 (COVID-19) that will be used in this study will be that stated by the FDA guides [26], as follows: Anyone who has at least one of the following symptoms for two days or more should be tested to detect SARS-CoV-2 nucleic acid in a clinical sample: